BDBM747326 N-(2-dimethylaminoethyl)-1-[4-[4-[[5-[(2S, 3R, 4S, 5S, 6R)-6-ethyl-3,4,5-trihydroxy-tetrahydropyran-2-yl]-2-methyl-phenyl] methyl] phenyl] butyrylamino] cyclohexyl formamide::US12324812, Example 1

SMILES CC[C@H]1O[C@@H](c2ccc(C)c(Cc3ccc(CCCC(=O)NC4(C(=O)NCCN(C)C)CCCCC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 747326   

TargetSodium/glucose cotransporter 1(Human)
Sunshine Lake Pharma Co.

US Patent
LigandPNGBDBM747326(N-(2-dimethylaminoethyl)-1-[4-[4-[[5-[(2S, 3R, 4S,...)
Affinity DataIC50: 0.220nMAssay Description:Test Purpose:the following methods can be used to determine the inhibitory activity of the compounds described in the invention on SGLT-1.Test Materi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/3/2025
Entry Details
US Patent